- Previous Close
6.79 - Open
7.08 - Bid 7.63 x --
- Ask 7.63 x --
- Day's Range
7.05 - 8.05 - 52 Week Range
3.74 - 20.50 - Volume
4,938,451 - Avg. Volume
1,362,267 - Market Cap (intraday)
754.488M - Beta (5Y Monthly) 1.79
- PE Ratio (TTM)
-- - EPS (TTM)
-8.92 - Earnings Date Nov 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.83
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
www.canopygrowth.com1,029
Full Time Employees
March 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: WEED.TO
View More
Related Videos: WEED.TO
Performance Overview: WEED.TO
Trailing total returns as of 2024-11-04, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WEED.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WEED.TO
View MoreValuation Measures
Market Cap
576.17M
Enterprise Value
1.00B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.91
Price/Book (mrq)
1.08
Enterprise Value/Revenue
3.50
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-259.94%
Return on Assets (ttm)
-3.83%
Return on Equity (ttm)
-87.26%
Revenue (ttm)
287.1M
Net Income Avi to Common (ttm)
-602.3M
Diluted EPS (ttm)
-8.92
Balance Sheet and Cash Flow
Total Cash (mrq)
196.92M
Total Debt/Equity (mrq)
117.00%
Levered Free Cash Flow (ttm)
17.19M